Article
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
Blood - 7 Feb 2013
Marsh Rebecca A, Rao Kanchan, Satwani Prakash, Lehmberg Kai, Müller Ingo, Li Dandan, Kim Mi-Ok, Fischer Alain, Latour Sylvain, Sedlacek Petr, Barlogis Vincent, Hamamoto Kazuko, Kanegane Hirokazu, Milanovich Sam, Margolis David A, Dimmock David, Casper James, Douglas Dorothea N, Amrolia Persis J, Veys Paul, Kumar Ashish R, Jordan Michael B, Bleesing Jack J, Filipovich Alexandra H
Abstract excerpt
There have been no studies on patient outcome after allogeneic hematopoietic cell transplantation (HCT) in patients with X-linked inhibitor of apoptosis (XIAP) deficiency. To estimate the success of HCT, we conducted an international survey of transplantation outcomes. Data were reported for 19 patients. Seven patients received busulfan-containing myeloablative conditioning (MAC) regimens. Eleven patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
